Bristol Myers Squibb Shares Outstanding 2006-2021 | BMY

Bristol Myers Squibb shares outstanding history from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Bristol Myers Squibb shares outstanding for the quarter ending September 30, 2021 were 2.243B, a 2.05% decline year-over-year.
  • Bristol Myers Squibb 2020 shares outstanding were 2.258B, a 31.89% increase from 2019.
  • Bristol Myers Squibb 2019 shares outstanding were 1.712B, a 4.58% increase from 2018.
  • Bristol Myers Squibb 2018 shares outstanding were 1.637B, a 0.91% decline from 2017.
Bristol Myers Squibb Annual Shares Outstanding
(Millions of Shares)
2020 2,258
2019 1,712
2018 1,637
2017 1,652
2016 1,680
2015 1,679
2014 1,670
2013 1,662
2012 1,688
2011 1,717
2010 1,727
2009 1,978
2008 1,999
2007 1,977
2006 1,963
2005 1,983
Bristol Myers Squibb Quarterly Shares Outstanding
(Millions of Shares)
2021-09-30 2,243
2021-06-30 2,252
2021-03-31 2,265
2020-12-31 2,258
2020-09-30 2,290
2020-06-30 2,263
2020-03-31 2,258
2019-12-31 1,712
2019-09-30 1,634
2019-06-30 1,637
2019-03-31 1,637
2018-12-31 1,637
2018-09-30 1,636
2018-06-30 1,636
2018-03-31 1,640
2017-12-31 1,652
2017-09-30 1,645
2017-06-30 1,650
2017-03-31 1,671
2016-12-31 1,680
2016-09-30 1,679
2016-06-30 1,679
2016-03-31 1,680
2015-12-31 1,679
2015-09-30 1,678
2015-06-30 1,667
2015-03-31 1,676
2014-12-31 1,670
2014-09-30 1,670
2014-06-30 1,669
2014-03-31 1,666
2013-12-31 1,662
2013-09-30 1,662
2013-06-30 1,660
2013-03-31 1,655
2012-12-31 1,688
2012-09-30 1,666
2012-06-30 1,701
2012-03-31 1,706
2011-12-31 1,717
2011-09-30 1,715
2011-06-30 1,722
2011-03-31 1,714
2010-12-31 1,727
2010-09-30 1,726
2010-06-30 1,728
2010-03-31 1,725
2009-12-31 1,978
2009-09-30 1,984
2009-06-30 1,983
2009-03-31 1,981
2008-12-31 1,999
2008-09-30 2,002
2008-06-30 2,006
2008-03-31 2,008
2007-12-31 1,977
2007-09-30 2,012
2007-06-30 2,006
2007-03-31 1,997
2006-12-31 1,963
2006-09-30 1,992
2006-06-30 1,994
2006-03-31 1,988
2005-12-31 1,983
2005-09-30 1,984
2005-06-30 1,984
2005-03-31 1,981
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $138.972B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $16.992B 34.48
QIAGEN (QGEN) Netherlands $11.128B 18.85
Biohaven Pharmaceutical Holding (BHVN) United States $7.780B 0.00
Emergent Biosolutions (EBS) United States $2.486B 8.94
Arcus Biosciences (RCUS) United States $2.230B 0.00
Myovant Sciences (MYOV) United Kingdom $1.231B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.064B 0.00
Zymeworks (ZYME) Canada $0.466B 0.00
SQZ Biotechnologies (SQZ) United States $0.214B 0.00
Ambrx Biopharma (AMAM) United States $0.193B 0.00
Enzo Biochem (ENZ) United States $0.153B 19.75